most likely the FDA timeline will be fast tracked as DurAVR could be eligible for breakthrough designation!
in that case price target increases from $66 to $166 imo DYOR nfa
$66.32 price target - Evolution Capital initiation of coverage, page-11
-
- There are more pages in this discussion • 98 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.12 |
Change
-0.230(1.33%) |
Mkt cap ! $326.7M | |||
| Open | High | Low | Value | Volume |
| $17.00 | $17.44 | $16.95 | $173.0K | 10.16K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100 | $17.12 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.21 | 1 | 1 |
View Market Depth
| Last trade - 15.30pm 19/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |